Vertebral fractures up with long-term delay of denosumab
(HealthDay)—Compared with on-time dosing, delay of denosumab by more than 16 weeks is associated with an increased risk for vertebral fractures, according to a study published online July 28 in the Annals of Internal Medicine.
Jul 28, 2020
0
1